Knight Therapeutics Inc. (04K)
FSX
5.95
0.00 (0.00%)
Closed
Aug 25, 2026
Day's Range
5.955.95
52 wk Range
3.466.20
Financial Statements - 04K - Knight Therapeutics Inc.
Revenue
450.08M▲ 21.2%
Net Income
-5.37M▼ 224.1%Net Margin -1.2%
EBITDA
58.15M▼ 17.8%
Free Cash Flow
35.26M▲ 633.4%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 450.08M | 371.30M | 328.19M | 293.56M | 243.47M | 199.51M |
| Cost of Goods | 249.85M | 196.89M | 175.54M | 155.50M | 128.06M | 117.82M |
| Gross Profit | 200.23M | 174.40M | 152.65M | 138.06M | 115.41M | 81.69M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -2.35M | 7.39M | 6.37M | -17.06M | -12.83M | -30M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -136K | -6.53M | -28.44M | -30.93M | 15.75M | 51.16M |
| Pre Tax Income | -6.70M | 2.05M | -21.98M | -43.96M | 6.69M | 32.08M |
| Income Tax | -1.32M | -2.28M | -5.15M | -14.06M | -8.98M | 325K |
| Net Income | -5.37M | 4.33M | -16.83M | -29.89M | 15.67M | 31.76M |
| EPS Basic | -0.05 | 0.04 | -0.16 | -0.26 | 0.13 | 0.32 |
| EPS Diluted | -0.05 | 0.04 | -0.16 | -0.26 | 0.13 | 0.32 |
| Basic Shares Outstanding | 99.56M | 101.04M | 167.05M | 170.95M | 185.22M | 196.09M |
| Diluted Shares Outstanding | 99.56M | 101.04M | 167.05M | 170.95M | 185.22M | 196.09M |
| Ebit | 3.72M | 11.27M | -9.50M | -37.36M | 10.30M | 35.48M |
| Ebitda | 58.15M | 70.78M | 72.24M | 60.21M | 42.59M | 28.63M |
| Net Income Continuous Operations | -5.37M | 4.33M | -16.83M | -29.89M | 15.67M | 31.76M |
| Minority Interests | - | - | - | - | 0 | 10.30M |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
